Drug Res (Stuttg) 2026; 76(01): e1
DOI: 10.1055/a-2798-3571
Correction

Correction: Treatment of K562 Cells with ABL Kinase Inhibitors Reveals Differential Metabolic Profiles

Authors

  • Pranay Renukuntla

    1   Department of Analytical and Structural Chemistry, CSIR - Indian Institute of Chemical Technology, Hyderabad, India (Ringgold ID: RIN62391)
    2   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India (Ringgold ID: RIN550336)
  • Sai Charitha Mullaguri

    3   Molecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India (Ringgold ID: RIN28552)
  • Divya Presingu

    1   Department of Analytical and Structural Chemistry, CSIR - Indian Institute of Chemical Technology, Hyderabad, India (Ringgold ID: RIN62391)
    2   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India (Ringgold ID: RIN550336)
  • Rama Krishna Kancha

    3   Molecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India (Ringgold ID: RIN28552)
  • Jagadeshwar Reddy Thota

    1   Department of Analytical and Structural Chemistry, CSIR - Indian Institute of Chemical Technology, Hyderabad, India (Ringgold ID: RIN62391)
    2   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India (Ringgold ID: RIN550336)

10.1055/a-2769-1965

In the above-mentioned article the affiliations of Sai Charitha Mullaguri and Rama Krishna Kancha were indicated incorrectly. Correct is: Molecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, 500007, Hyderabad, India. Additionally the postcode has been added to the other affiliations. This was corrected in the online version on February 02, 2026.



Publication History

Article published online:
11 February 2026

© 2026. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany